ArticleBMC cancer2024

The efficacy and safety of Radiofrequency ablation combined with Lenvatinib plus Sintilimab in Unresectable Hepatocellular Carcinoma: a real-world study.

Xishu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.